dermatomyositis: Dermatomyositis (DM) is a type of idiopathic inflammatory myopathy characterized by evocative skin lesions and symmetrical proximal muscle weakness.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
176 |
4. Check minimum number of eventsNone |
176 |
5. Include endpointsNone |
176 |
6. Filter based on genotype QC (FinnGen only) |
176 |
Control definitions (FinnGen only)
- Control exclude
- M13_SYSTCONNECT
Extra metadata
- Level in the ICD hierarchy
- 4
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- M33
- Name in latin
- Alia dermatomyositis
Similar endpoints
↥List of similar endpoints to
Other dermatomyositis
based on the number of shared cases.
Similar with more cases:
- Dermatopolymyositis (FG)
- Dermatopolymyositis
- Systemic connective tissue disorders
- Autoimmune diseases related-to ILD
- Finngen Rheumatological endpoints
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 994 | 672 | 312 |
| Only index persons | 759 | 525 | 234 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.02 | 0.02 | 0.01 |
| Only index persons | 0.02 | 0.02 | 0.01 |
| Median age at first event (years) | |||
| Whole population | 54.13 | 53.64 | 54.89 |
| Only index persons | 51.33 | 51.38 | 51.23 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 176 | 123 | 53 |
| Unadjusted period prevalence (%) | 0.04 | 0.04 | 0.02 |
| Median age at first event (years) | 53.89 | 52.72 | 56.63 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 163
- Matched controls
- 1629
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
M33.1
ICD-10 Finland
Other dermatomyositis
+∞
205.8
151
*
M33.9
ICD-10 Finland
Dermatopolymyositis, unspecified
+∞
73.6
65
*
202
Kela drug reimbursment
Connective tissue diseases, rheumatoid arthritis and comparable disease
30.6
68.5
99
78
L04AX03
ATC
methotrexate; systemic (immunosuppressants)
20.5
44.8
71
59
P01BA02
ATC
hydroxychloroquine; oral
19.4
41.2
66
55
M33.2
ICD-10 Finland
Polymyositis
+∞
40.3
37
*
L04AX01
ATC
azathioprine; systemic
26.7
37.1
52
28
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
16.7
34.5
58
52
H02AB06
ATC
prednisolone; systemic
9.0
33.2
133
536
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
7.1
29.7
112
385
NXL00
NOMESCO Finland
Biopsy of muscle
+∞
23.5
22
*
M35.9
ICD-10 Finland
Systemic involvement of connective tissue, unspecified
+∞
23.5
22
*
NK4XE
NOMESCO Finland
Joint ultrasound examination not elsewhere classified
12.9
19.9
36
35
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
9.0
17.7
39
55
L04AA06
ATC
mycophenolic acid; systemic
36.0
17.5
22
7
M05BA04
ATC
alendronic acid; oral
8.0
17.5
42
68
L04AD01
ATC
ciclosporin; systemic
23.2
17.0
24
12
M60.9
ICD-10 Finland
Myositis, unspecified
+∞
17.0
16
*
M33.0
ICD-10 Finland
Juvenile dermatomyositis
+∞
17.0
16
*
L01BA01
ATC
methotrexate; systemic (folic acid analog.)
13.8
16.3
28
24
G72.9
ICD-10 Finland
Myopathy, unspecified
62.7
15.1
17
*
H02AB07
ATC
prednisone; oral
5.1
14.9
53
141
71600
ICD-8 Finland
Polymyositis and dermatomyositis, Dermatomyositis
+∞
14.8
14
*
NJ3CG
NOMESCO Finland
Extensive MRI examination of extremities with median high magnet
+∞
13.7
13
*
7103B
ICD-9 Finland
Diffuse diseases of connective tissue, Dermatomyositis[DERMATOMYOSITIS ADULTORUM]
+∞
13.7
13
*
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
10.3
12.8
25
28
M05BA07
ATC
risedronic acid; oral
11.9
12.2
22
21
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
3.6
11.8
67
263
J99.1*M33.9
ICD-10 Finland
Respiratory disorders in dermatopolymyositis
+∞
11.6
11
*
M33
ICD-10 Finland
Dermatopolymyositis
+∞
11.6
11
*
L04AA01
ATC
[U] ciclosporin; systemic
22.0
11.4
16
8
XQ848
NOMESCO Finland
Dermatological photography
17.1
11.1
17
11
D07AB08
ATC
desonide; topical
5.2
10.9
35
81
M35.0
ICD-10 Finland
Sicca syndrome [Sjögren]
64.3
10.8
12
*
NJ3BG
NOMESCO Finland
MRI examination of extremities with high intensity magnet
+∞
10.5
10
*
TNX10
NOMESCO Finland
Arthrocentesis, unspecified region, unspecified region
6.7
10.2
26
45
ZX120
NOMESCO Finland
Intravenous
4.9
10.1
34
83
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.9
9.9
88
464
D07AC01
ATC
betamethasone; topical
3.1
9.9
73
339
J99.1*M33.2
ICD-10 Finland
Respiratory disorders in polymyositis
+∞
9.5
9
*
M35.1
ICD-10 Finland
Other overlap syndromes
+∞
9.5
9
*
J99.1
ICD-10 Finland
Respiratory disorders in other diffuse connective tissue disorders
+∞
9.5
9
*
L30.9
ICD-10 Finland
Dermatitis, unspecified
3.5
9.0
45
158
R4110
NOMESCO Finland
Physiotherapy
3.0
8.9
65
298
J84.1
ICD-10 Finland
Other interstitial pulmonary diseases with fibrosis
12.6
8.8
15
13
R4120
NOMESCO Finland
Occupational therapy
6.2
8.7
23
42
UGC12
NOMESCO Finland
Flexible bronchoscopy
5.6
8.7
25
51
L93.0
ICD-10 Finland
Discoid lupus erythematosus
+∞
8.4
8
*
QBA99
NOMESCO Finland
Other local destruction of skin of trunk
35.3
8.2
10
*
NGA20
NOMESCO Finland
Exploration of soft tissue knee or lower leg, open
35.3
8.2
10
*
J84.9
ICD-10 Finland
Interstitial pulmonary disease, unspecified
11.6
8.0
14
13
TPH04
NOMESCO Finland
Cathetrisation of vein
3.3
7.7
42
156
D07AC13
ATC
mometasone; topical
2.8
7.6
59
276
M60.8
ICD-10 Finland
Other myositis
83.7
7.5
8
*
ND2AA
NOMESCO Finland
Hand and fingers X-ray examination
4.4
6.7
24
62
E0000UV
ATC
NA
2.4
6.5
74
418
M81.4
ICD-10 Finland
Drug-induced osteoporosis
72.5
6.5
7
*
D07AB02
ATC
hydrocortisone butyrate; topical
2.6
6.4
56
276
C03CA01
ATC
furosemide; systemic
2.6
6.4
54
261
XG410
NOMESCO Finland
Flow-volume spirometry
6.8
6.3
15
24
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
6.8
6.3
15
24
318
Kela drug reimbursment
Teriparatide
+∞
6.3
6
*
H05AA02
ATC
teriparatide; parenteral
+∞
6.3
6
*
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
3.3
6.2
31
107
J18.9
ICD-10 Finland
Pneumonia, unspecified
2.8
6.2
44
192
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
4.7
6.2
20
47
R50.9
ICD-10 Finland
Fever, unspecified
3.3
6.2
31
108
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
3.3
6.2
31
108
GD1ED
NOMESCO Finland
Extensive high resolution CT examination of lungs
7.7
6.1
13
18
E000001
ATC
NA
2.8
6.0
41
175
JN4BD
NOMESCO Finland
Extensive body CT
3.3
6.0
30
104
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
40
40
12.65
36.79
1.5
1.1
g/l
0.2
0.2
2.44
40
40
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
40
43
11.74
34.97
1.5
1.1
g/l
1.1
1.3
1.50
40
43
(3037522) Nuclear Ab [Titer] in Serum
75
177
6.64
33.09
2.0
1.3
titre
683.2
434.3
0.84
37
35
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
31
38
9.69
24.29
2.0
1.4
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
18
10
19.94
22.39
1.3
1.0
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
18
10
19.94
22.39
1.3
1.0
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
18
10
19.94
22.39
1.3
1.0
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
18
11
18.11
21.41
1.3
1.0
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
18
11
18.11
21.41
1.3
1.0
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
18
11
18.11
21.41
1.3
1.0
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
104
441
4.32
20.61
16.3
4.9
—
—
—
0
0
(3023420) DNA double strand Ab [Units/volume] in Serum
19
15
14.08
19.75
1.6
1.2
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
142
798
5.03
18.12
19.7
9.5
e9/l
4.1
4.1
0.10
137
705
(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum
15
10
16.30
16.95
1.1
1.1
—
—
—
0
0
(40758558) Short blood count panel - Blood
78
366
3.03
11.54
13.0
6.7
—
—
—
0
0
(3018418) pH of Serum or Plasma
83
416
2.88
10.72
4.9
3.7
ph
7.4
7.4
0.60
11
77
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
20
37
5.97
10.67
1.2
1.4
iu/ml
550.1
0.1
—
6
5
(3017181) Myelocytes/100 leukocytes in Blood
36
115
3.68
9.86
7.3
4.6
%
0.7
0.7
0.01
13
37
(3017143) Hepatitis C virus Ab [Presence] in Serum
43
159
3.26
9.36
1.4
1.5
—
—
—
0
0
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
20
42
5.24
9.32
1.4
2.4
g/l
37.5
38.1
0.14
20
37
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
18
35
5.61
9.09
3.9
2.3
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
33
105
3.64
9.06
7.6
4.8
%
0.2
0.2
0.04
12
33
(3025159) Blasts/100 leukocytes in Blood
33
105
3.64
9.06
7.1
4.6
%
0.0
0.0
0.00
11
30
(3002179) Metamyelocytes/100 leukocytes in Blood
33
105
3.64
9.06
6.0
4.7
%
1.3
0.5
—
10
26
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
109
668
2.66
8.99
9.4
6.6
mmol/l
1.2
1.2
0.09
98
562
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
21
48
4.83
8.88
1.3
2.2
g/l
3.1
2.9
0.47
21
40
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
14
22
6.83
8.67
5.4
2.6
%
62.4
62.3
0.01
14
22
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
48
201
2.91
8.36
1.5
1.5
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
102
626
2.50
8.09
20.3
9.0
e9/l
0.0
0.0
0.06
92
506
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
21
52
4.45
8.06
1.3
2.1
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
21
52
4.45
8.06
1.3
2.1
g/l
7.2
7.2
0.03
21
41
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
21
52
4.45
8.06
1.3
2.1
g/l
3.6
3.5
0.10
21
38
(3004588) Protein electrophoresis panel - Serum or Plasma
27
81
3.76
8.04
1.3
2.9
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
88
508
2.46
7.94
5.5
3.5
e6/l
44.9
86.7
0.43
62
349
(3021879) Hepatitis B virus core Ab [Presence] in Serum
31
103
3.44
7.94
1.2
1.5
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
13
21
6.60
7.83
5.1
2.0
e9/l
4.3
6.0
1.12
13
21
(3012095) Magnesium [Moles/volume] in Serum or Plasma
50
225
2.71
7.54
5.4
3.4
mmol/l
0.8
0.8
0.32
45
213
(3002582) Erythrocytes [#/volume] in Urine
77
430
2.41
7.34
4.2
2.9
e6/l
182.8
211.9
0.05
61
323
(40768443) Skin Pathology biopsy report
22
61
3.98
7.29
1.3
1.2
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
72
392
2.42
7.25
4.3
2.8
e6/l
0.2
0.5
1.49
54
287
(3007164) IgA [Mass/volume] in Serum or Plasma
60
301
2.51
7.21
2.1
1.5
g/l
2.2
2.5
0.57
45
175
(3052851) Hemolysis interference index of Serum or Plasma
18
43
4.55
7.20
2.6
2.8
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
132
945
2.59
7.04
8.7
4.3
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
57
285
2.48
6.86
3.3
2.4
e6/l
3.3
5.3
1.58
52
253
(3020630) Protein [Mass/volume] in Serum or Plasma
28
96
3.28
6.79
1.3
3.0
g/l
64.6
66.6
0.68
28
88
(36304419) Bacteria [Presence] in Urine
69
380
2.34
6.67
4.4
2.7
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
105
695
2.27
6.47
5.5
3.7
estimate
0.0
0.0
0.00
17
141
(3035350) Ketones [Presence] in Urine by Test strip
103
680
2.24
6.34
5.6
3.7
estimate
0.0
0.0
0.00
18
143
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
81
488
2.22
6.23
4.9
2.9
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
103
688
2.20
6.06
7.8
5.0
estimate
0.0
0.0
0.00
18
143
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
59
315
2.31
6.03
2.5
2.0
mg/l
3.9
3.2
0.97
54
268
(3015736) pH of Urine
86
536
2.18
6.02
4.6
3.4
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
35
146
2.74
6.02
2.3
1.6
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
16
41
4.19
5.86
1.1
1.1
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
62
342
2.25
5.84
5.0
4.1
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
91
586
2.14
5.80
3.2
2.2
nmol/l
75.1
77.4
0.36
85
518
(3011397) Hemoglobin [Presence] in Urine by Test strip
57
310
2.24
5.51
5.2
3.8
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
46
229
2.37
5.46
3.4
2.5
e6/l
0.6
0.8
0.74
31
125
(3000494) Fungus identified in Specimen by Culture
37
168
2.52
5.35
1.9
1.3
—
—
—
0
0
(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
11
22
5.27
5.33
1.2
1.4
—
—
—
0
0
(3019060) Gas panel - Arterial blood
23
82
3.08
5.21
7.9
4.1
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
11
23
5.03
5.08
1.2
1.5
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
57
320
2.16
5.04
9.2
4.4
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
27
108
2.77
5.00
1.3
1.2
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
10
20
5.24
4.84
2.2
1.6
—
—
—
0
0
(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum
8
7
11.89
4.83
1.1
1.4
—
—
—
0
0
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
32
143
2.51
4.76
9.7
7.5
kpa
5.4
5.0
0.95
27
137
(3027801) Oxygen [Partial pressure] in Arterial blood
32
143
2.51
4.76
9.7
7.5
kpa
11.2
12.4
0.65
27
137
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
20
70
3.10
4.67
1.6
2.4
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
40
206
2.22
4.32
2.1
1.8
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
8
9
9.24
4.32
2.6
2.2
—
—
—
0
0
(44790049)
8
9
9.24
4.32
2.4
1.3
—
—
—
0
0
(44806118)
8
9
9.24
4.32
2.4
1.3
—
—
—
0
0
(44790047)
8
9
9.24
4.32
2.4
1.3
—
—
—
0
0
(44790048)
8
9
9.24
4.32
2.4
1.3
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
41
217
2.16
4.13
3.7
2.7
e6/l
3.4
2.9
0.17
26
115
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
11
28
4.12
4.04
1.2
1.1
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
68
440
1.89
3.89
2.7
3.0
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
30
144
2.31
3.81
10.2
7.5
mmol/l
1.8
1.2
0.32
24
111
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
9
16
5.86
3.71
2.1
1.3
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
7
9
8.04
3.59
2.7
1.3
—
—
—
0
0
(3000991) Gas panel - Venous blood
24
107
2.44
3.58
8.2
8.0
—
—
—
0
0
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
6
6
10.29
3.52
1.0
1.2
iu/ml
94.5
84.2
—
6
6
(4035726)
27
130
2.27
3.40
1.3
1.4
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
58
372
1.83
3.33
4.4
3.2
ng/l
1025.2
1447.9
0.66
53
319
(3026389) Candida sp identified in Specimen by Organism specific culture
8
15
5.53
3.23
1.0
1.2
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
7
11
6.57
3.21
1.0
1.1
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
55
351
1.82
3.20
1.3
1.2
u/ml
0.6
1.7
1.11
11
104
(46235355) HIV 1 and 2 tests - Meaningful Use set
41
238
1.94
3.18
1.7
1.8
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
9
20
4.68
3.16
1.2
1.4
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
9
20
4.68
3.16
1.2
1.4
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
10
29
3.60
3.09
2.2
1.7
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
7
12
6.02
3.05
1.0
1.3
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
7
12
6.02
3.05
1.0
1.3
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
9
21
4.46
3.04
1.0
1.5
—
—
—
0
0
(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum
5
5
10.24
2.99
4.0
1.6
ug/l
58.6
82.8
—
5
5
(3004616) Nuclear Ab [Presence] in Serum
8
17
4.88
2.95
1.3
1.2
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
8
17
4.88
2.95
2.5
1.6
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
8
18
4.60
2.83
1.6
2.4
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
10
31
3.36
2.82
2.2
1.7
—
—
—
0
0
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
21
99
2.27
2.78
1.0
1.3
—
46.7
—
0
5
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
27
142
2.06
2.74
2.0
1.7
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
7
15
4.81
2.62
1.3
1.6
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
29
162
1.95
2.50
2.2
4.5
ug/l
3.6
76.9
0.86
23
134
(3016650) Hepatitis A virus Ab [Presence] in Serum
7
16
4.51
2.50
1.0
1.0
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
7
16
4.51
2.50
2.1
2.7
—
—
—
0
0
(3038026) Centromere Ab [Units/volume] in Serum
5
8
6.39
2.38
1.4
1.3
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
128
1441
0.59
2.36
4.9
4.9
mmol/l
2.9
2.8
0.94
122
1320
(3000492) Spirometry study
22
115
2.04
2.28
2.9
1.4
—
—
—
0
0
(4268621)
7
18
4.00
2.27
2.0
1.8
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
7
18
4.00
2.27
1.3
1.6
—
—
—
0
0
(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum
5
9
5.68
2.23
1.4
1.1
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
6
14
4.40
2.17
4.0
4.4
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
6
14
4.40
2.17
1.2
1.4
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
6
14
4.40
2.17
1.0
1.0
—
—
—
0
0
(4306422)
8
25
3.30
2.12
1.1
1.2
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
39
252
1.70
2.11
1.2
1.2
iu/ml
31.1
42.4
—
9
84
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
122
1380
0.62
2.11
4.2
4.4
mmol/l
5.6
5.9
2.30
117
1262
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
8
26
3.17
2.04
2.1
1.7
—
—
—
0
0
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
24
136
1.89
1.99
3.0
2.3
g/l
0.2
0.2
0.70
24
126
(1761868) Lipid panel - Serum or Plasma
36
528
0.60
1.99
2.5
2.7
—
—
—
0
0
(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay
7
21
3.43
1.98
1.6
3.0
u/ml
31.7
86.7
—
7
21
(3041096) Erythrocytes [Presence] in Urine by Automated
55
394
1.58
1.98
4.9
3.2
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
8
27
3.05
1.96
1.8
1.7
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
127
1416
0.63
1.92
4.5
4.4
mmol/l
4.8
4.7
0.52
121
1301
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
7
22
3.27
1.90
3.6
1.2
—
—
—
0
0
(3020891) Body temperature
12
53
2.36
1.85
13.8
4.1
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
30
187
1.73
1.84
1.2
1.2
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
50
357
1.56
1.82
3.9
2.6
umol/l
330.4
8963.3
2.48
44
305
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
70
538
1.50
1.81
5.9
3.7
—
—
—
0
0
(3012544) pH of Venous blood
22
126
1.85
1.78
3.4
3.2
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
5
13
3.92
1.72
1.2
2.3
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
5
13
3.92
1.72
1.2
2.3
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
5
13
3.92
1.72
1.2
2.3
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
127
1406
0.65
1.68
4.5
4.3
mmol/l
1.5
1.5
0.69
121
1285
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
8
31
2.65
1.68
1.1
1.0
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
38
259
1.60
1.67
1.8
1.6
nmol/l
910.5
1272.2
2.28
31
195
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
11
49
2.33
1.67
1.4
1.3
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
6
20
3.07
1.59
2.0
1.6
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
12
57
2.19
1.59
1.1
1.4
—
—
—
0
0
(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood
12
57
2.19
1.59
4.8
3.4
%
39.1
45.0
0.33
12
57
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
10
44
2.35
1.56
2.0
1.8
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
8
33
2.49
1.56
2.1
1.3
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
23
140
1.74
1.54
2.2
1.7
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
5
15
3.40
1.53
1.2
2.0
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
43
308
1.52
1.53
1.7
1.8
mg/l
1.3
1.2
0.15
31
242
(3048929) Epstein Barr virus Ab [Presence] in Serum
10
45
2.30
1.49
1.1
1.3
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
5
17
3.00
1.37
1.2
1.9
—
—
—
0
0
(3014576) Chloride [Moles/volume] in Serum or Plasma
26
170
1.62
1.36
13.4
6.4
mmol/l
103.9
104.0
0.04
26
164
(3029937) Albumin [Presence] in Urine by Test strip
50
380
1.44
1.32
6.7
3.9
estimate
0.0
0.0
0.00
17
142
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
12
62
2.00
1.31
2.2
2.5
u/l
45.8
42.4
0.30
12
56
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
16
92
1.81
1.30
1.4
1.6
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
123
1350
0.70
1.27
4.1
3.9
mmol/l
1.3
1.3
0.56
118
1225
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
5
19
2.68
1.22
1.6
1.5
—
—
—
0
0
(3018677) aPTT in Platelet poor plasma by Coagulation assay
30
209
1.52
1.21
2.6
1.7
s
34.0
29.5
0.95
30
203
(3024891) Influenza virus A+B Ag [Presence] in Specimen
8
38
2.16
1.20
1.1
1.2
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
34
244
1.49
1.20
1.2
1.2
u/ml
8.8
20.2
—
9
86
(3042936) Bacteria identified in Isolate by Culture
29
201
1.53
1.20
3.7
2.0
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
10
50
2.06
1.19
2.3
2.1
—
—
—
0
0
(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight
5
20
2.54
1.16
1.6
1.1
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
5
21
2.42
1.10
3.4
1.1
—
—
—
0
0
(40761535) Cells panel - Urine sediment
16
101
1.64
0.97
5.0
3.5
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
0
31
0.00
0.97
0.0
1.3
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
11
62
1.83
0.96
1.8
1.3
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
67
561
1.31
0.95
9.0
7.3
inr
1.3
1.2
0.26
18
162
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
7
37
1.93
0.95
1.1
1.1
—
17.0
—
0
6
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
13
78
1.72
0.94
1.0
1.0
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
13
78
1.72
0.94
1.2
1.7
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
34
258
1.39
0.90
1.6
1.5
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
15
225
0.64
0.89
3.0
4.5
%
22.4
21.6
—
8
114
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
8
138
0.56
0.87
1.4
1.6
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
78
677
1.27
0.82
5.0
4.0
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
8
133
0.58
0.77
1.8
1.9
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
104
941
1.26
0.75
3.6
3.0
u/l
53.9
46.2
0.47
99
888
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
10
61
1.68
0.70
15.8
9.0
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
152
1448
1.36
0.68
29.3
13.0
mg/l
20.9
23.1
0.38
136
1122
(3019832) Treponema pallidum Ab [Presence] in Serum
15
103
1.50
0.67
1.2
1.7
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
54
459
1.25
0.66
2.6
2.3
—
—
—
0
0
(3022145) Colonoscopy Study observation
24
182
1.37
0.66
1.4
1.3
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
145
1515
0.76
0.66
21.6
12.6
—
—
—
0
0
(3028626) Oxygen [Partial pressure] in Capillary blood
5
29
1.74
0.64
2.6
1.8
kpa
8.0
8.0
—
5
24
(1616796) Gas panel - Central venous blood
5
29
1.74
0.64
2.2
2.0
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
8
50
1.63
0.62
1.3
1.6
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
5
30
1.69
0.62
1.8
1.9
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
5
30
1.69
0.62
1.2
1.1
—
—
—
0
0
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
0
22
0.00
0.59
0.0
1.0
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
0
22
0.00
0.59
0.0
1.3
—
—
—
0
0
(1002224) Polysomnography panel
8
53
1.53
0.59
1.0
1.1
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
124
1314
0.81
0.58
5.9
5.5
mmol/mol
40.5
39.6
0.48
119
1218
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
0
23
0.00
0.58
0.0
1.0
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
6
35
1.74
0.58
1.0
1.7
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
60
525
1.22
0.56
3.5
3.6
ng/l
133.6
30.1
0.97
49
348
(4010399)
14
100
1.43
0.53
2.4
1.3
—
—
—
0
0
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
12
83
1.48
0.53
14.8
5.7
mmol/l
26.8
25.0
0.67
12
83
(3000330) Specific gravity of Urine by Test strip
9
64
1.43
0.52
2.6
3.6
—
—
—
0
0
(3044889) 12 lead EKG panel
107
994
1.20
0.51
5.3
3.9
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
84
913
0.85
0.48
3.0
3.1
—
—
—
0
0
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
10
68
1.50
0.48
3.1
2.3
%
1.3
1.1
—
10
68
(3013512) EKG study
35
412
0.81
0.47
4.4
3.8
—
—
—
0
0
(3022621) pH of Urine by Test strip
13
94
1.41
0.47
3.7
2.8
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
7
51
1.39
0.44
1.3
1.1
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
7
51
1.39
0.44
1.3
1.1
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
13
172
0.74
0.43
11.0
6.7
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
10
70
1.45
0.42
2.6
3.5
mmol/l
2.0
1.2
—
10
52
(3003694) ABO and Rh group [Type] in Blood
45
393
1.19
0.42
1.3
1.4
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
8
58
1.40
0.42
1.5
1.9
—
—
—
0
0
(3027315) Oxygen [Partial pressure] in Blood
5
33
1.53
0.41
8.8
3.1
kpa
7.7
8.7
—
5
33
(3012501) Base excess in Blood by calculation
5
33
1.53
0.41
8.8
3.1
mmol/l
3.7
3.0
—
5
21
(3013290) Carbon dioxide [Partial pressure] in Blood
5
33
1.53
0.41
8.8
3.1
kpa
5.4
5.1
—
5
33
(3007368) IgG [Mass/volume] in Cerebral spinal fluid
0
15
0.00
0.41
0.0
1.1
—
29.9
—
0
10
(3051014) Leukocytes [#/area] in Urine sediment by Automated count
0
15
0.00
0.41
0.0
2.0
—
2.2
—
0
5
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
0
17
0.00
0.41
0.0
1.8
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
0
17
0.00
0.41
0.0
1.8
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
0
17
0.00
0.41
0.0
1.8
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
0
17
0.00
0.41
0.0
1.8
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
0
17
0.00
0.41
0.0
1.8
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
0
17
0.00
0.41
0.0
1.8
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
0
17
0.00
0.41
0.0
1.0
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
5
34
1.48
0.40
4.2
1.7
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
0
18
0.00
0.40
0.0
1.2
—
—
—
0
0
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
0
18
0.00
0.40
0.0
1.3
—
31.9
—
0
18
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
0
18
0.00
0.40
0.0
1.8
—
10.7
—
0
6
(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma
5
35
1.44
0.39
1.8
2.7
u/ml
18.2
36.3
—
5
35
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
5
35
1.44
0.39
1.0
1.6
—
—
—
0
0
(3008295) Osmolality of Serum or Plasma
0
19
0.00
0.39
0.0
1.3
—
271.1
—
0
14
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
13
168
0.76
0.37
2.4
2.8
ug/l
0.7
0.7
—
8
111
(3043409) Potassium [Moles/volume] in Arterial blood
6
41
1.48
0.36
20.3
4.0
mmol/l
3.7
3.9
—
6
35
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
17
136
1.28
0.35
6.5
3.8
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
13
100
1.32
0.34
1.7
3.2
e9/l
99.7
73.2
—
7
80
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
39
344
1.17
0.33
2.2
2.4
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
35
307
1.17
0.32
7.1
3.9
kg/l
1.0
1.0
—
5
40
(3013139) Helicobacter pylori Ag [Presence] in Stool
12
93
1.31
0.31
1.2
1.3
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
61
564
1.12
0.27
2.3
1.9
pmol/l
90.6
96.9
0.63
32
277
(3012516) Albumin [Mass/volume] in Urine
41
373
1.13
0.24
3.4
3.1
mg/l
14.1
58.0
2.03
26
234
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
106
1101
0.91
0.22
5.5
4.2
pmol/l
14.9
14.7
0.18
98
996
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
0
11
0.00
0.21
0.0
2.3
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
0
11
0.00
0.21
0.0
2.3
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
0
11
0.00
0.21
0.0
2.3
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
0
11
0.00
0.21
0.0
2.3
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
0
11
0.00
0.21
0.0
1.3
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
1.7
—
—
—
0
0
(3000012) Reticulocyte production index
0
10
0.00
0.21
0.0
2.1
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
0
10
0.00
0.21
0.0
7.7
—
—
—
0
0
(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay
0
12
0.00
0.21
0.0
1.1
—
41.0
—
0
7
(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid
0
12
0.00
0.21
0.0
1.0
—
452.7
—
0
7
(3016724) Homocysteine [Moles/volume] in Serum or Plasma
0
12
0.00
0.21
0.0
1.6
—
12.9
—
0
12
(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid
0
12
0.00
0.21
0.0
1.0
—
293.7
—
0
7
(4027681)
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
36
394
0.89
0.21
1.7
1.6
mmol/l
1.5
1.4
0.33
30
327
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
0
13
0.00
0.21
0.0
6.4
—
—
—
0
0
(3000081) cloZAPine [Moles/volume] in Serum or Plasma
0
14
0.00
0.20
0.0
23.6
—
2079.9
—
0
14
(4146454)
0
14
0.00
0.20
0.0
3.9
—
—
—
0
0
(3008832) Norclozapine [Moles/volume] in Serum or Plasma
0
14
0.00
0.20
0.0
16.8
—
1069.3
—
0
14
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
6
50
1.21
0.20
1.2
1.1
—
—
—
0
0
(3019225) pH of Specimen
10
121
0.82
0.18
12.9
5.2
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
14
119
1.19
0.18
3.4
2.2
ml/min/173m2
88.6
64.0
—
5
48
(40768804) Tissue Pathology biopsy report
62
586
1.09
0.18
2.5
2.1
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
26
284
0.90
0.14
3.3
5.0
ug/l
2.3
2.0
0.16
21
253
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
132
1346
0.92
0.14
24.3
12.9
ml/min/173m2
88.5
81.8
2.18
119
1088
(4034850)
5
45
1.11
0.10
7.8
7.6
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
6
54
1.11
0.09
1.5
1.6
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
6
55
1.09
0.09
1.8
1.6
—
—
—
0
0
(3008898) HLA-B27 [Presence]
5
61
0.81
0.08
1.4
1.0
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
12
133
0.90
0.08
1.3
1.3
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
8
73
1.10
0.07
1.5
1.7
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
38
397
0.95
0.07
3.5
3.9
mg/mmol
3.1
9.4
1.65
19
239
(3025941) Bacteria identified in Stool by Culture
9
87
1.04
0.07
1.0
1.2
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
9
88
1.02
0.07
1.2
1.3
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
17
158
1.08
0.06
2.1
2.0
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
130
1315
0.96
0.06
5.8
4.9
mu/l
1.8
1.9
0.63
121
1193
(3020564) Creatinine [Moles/volume] in Serum or Plasma
153
1518
1.06
0.05
31.6
15.8
umol/l
71.9
74.3
0.27
153
1518
(3002256) Pathology report gross observation
19
179
1.07
0.05
1.4
1.2
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
11
101
1.10
0.04
1.5
1.3
iu/ml
60.3
133.1
—
5
39
(3009508) Creatinine [Moles/volume] in Urine
42
410
1.03
0.03
3.4
2.9
mmol/l
5.5
7.4
3.14
36
342
(3009542) Hematocrit [Volume Fraction] of Blood
130
1310
0.97
0.03
31.3
14.3
%
39.2
39.7
0.28
97
968
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
13
138
0.94
0.02
2.2
1.8
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
14
133
1.06
0.01
1.5
1.4
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
13
124
1.05
0.00
5.7
3.4
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
27
267
1.01
0.00
1.5
1.4
—
—
—
0
0
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40765096) Chromosome analysis panel by Banding
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3012565) Volume of 24 hour Urine
0
5
0.00
0.00
0.0
3.2
—
2180.0
—
0
5
(3037556) Urate [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3002619) Bacteria identified in Specimen by Culture
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3022313) Gas panel - Capillary blood
5
55
0.91
0.00
2.6
3.7
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
0
9
0.00
0.00
0.0
2.6
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
5
51
0.98
0.00
1.0
1.5
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
0
8
0.00
0.00
0.0
2.5
—
—
—
0
0
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3051593) INR in Capillary blood by Coagulation assay
0
8
0.00
0.00
0.0
19.9
—
—
—
0
0
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
0
6
0.00
0.00
0.0
1.0
—
147.3
—
0
6
(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid
0
5
0.00
0.00
0.0
1.0
—
17.2
—
0
5
(3001019) Free T4 and TSH panel - Serum or Plasma
6
69
0.87
0.00
3.2
2.0
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
0
9
0.00
0.00
0.0
2.6
—
—
—
0
0
(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
0
8
0.00
0.00
0.0
2.5
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
0
6
0.00
0.00
0.0
2.0
—
—
—
0
0
(3022689) Creatine [Moles/volume] in Urine
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3013005) Retinol [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.7
—
1.6
—
0
6
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
3.2
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(4024509)
0
9
0.00
0.00
0.0
1.3
—
—
—
0
0
(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction
0
9
0.00
0.00
0.0
1.1
—
204.1
—
0
9
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3019420) Tryptase [Mass/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.5
—
8.8
—
0
8
(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.5
—
30.5
—
0
8
(3032057) Clostridioides difficile [Presence] in Stool
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
0
7
0.00
0.00
0.0
2.0
—
—
—
0
0
(3020650) Glucose [Presence] in Urine
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
0
6
0.00
0.00
0.0
2.0
—
—
—
0
0
(40758292) HTLV I+II Ab panel - Serum
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(44813793)
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
0
9
0.00
0.00
0.0
2.6
—
—
—
0
0
(4198724)
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint M13_DERMATOMYOTH and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| M13_DERMATOMYOTH | 2.82 [2.11, 3.76] | < 0.001 |
| Birth year | 1.001 [0.99, 1.01] | 0.762 |
During the follow-up period (1.1.1998 — 31.12.2019), 120 out of 411 females with M13_DERMATOMYOTH died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| M13_DERMATOMYOTH | 3.103 [2.28, 4.22] | < 0.001 |
| Birth year | 0.985 [0.98, 0.99] | 0.002 |
During the follow-up period (1.1.1998 — 31.12.2019), 69 out of 201 males with M13_DERMATOMYOTH died.
Mortality risk
Mortality risk for people of age
years, who have M13_DERMATOMYOTH.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.228% | 0.515% |
| 5 | 1.755% | 3.094% |
| 10 | 4.592% | 7.916% |
| 15 | 9.262% | 14.67% |
| 20 | 16.456% | 24.478% |
Relationships between endpoints
↥Index endpoint: M13_DERMATOMYOTH – Other dermatomyositis
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data